Related by context. All words. (Click for frequent words.) 72 reinfarction 72 fractional shortening 71 nondiabetic patients 71 binary restenosis 70 nonfatal myocardial infarction 70 target lesion revascularization 70 plus GP IIb 69 PLX STROKE targeting 69 TAXUS p value 69 tirofiban 69 myocardial infarction ventricular fibrillation 69 Operative mortality 68 MACCE 68 refractory ischemia 68 LV ejection fraction 68 XIENCE V PROMUS Stent 68 XIENCE V demonstrated 68 LV dysfunction 68 ID TLR 68 Erythropoietic therapies may 68 NMIBC 68 nonfatal MI 68 morphometric vertebral fractures 68 periprocedural 68 nicardipine 68 unstable angina pectoris 68 mL/min/#.# m 2 68 deep venous thromboses 68 target vessel revascularization 68 neointimal hyperplasia 67 Target Vessel Revascularization 67 myocardial infarction stroke 67 TAXUS Express Stent 67 Patency 67 tenecteplase 67 Stent thrombosis 67 XIENCE V vs. 67 Target Lesion Revascularization TLR 67 bivalirudin monotherapy 67 diameter stenosis 67 unfractionated heparin UFH 67 symptomatic intracranial 67 repeat revascularization 67 rebleeding 67 Events MACE 66 baseline serum creatinine 66 IIIa inhibitor 66 nonfatal myocardial infarction MI 66 thromboembolic complications 66 graft occlusion 66 CK MB 66 metastatic malignant 66 Intracranial 66 mcg QD 66 segment binary restenosis 66 events MACE 66 left ventricular systolic 66 reintervention 66 fibrinolysis 66 cerebrovascular events 66 plus glycoprotein IIb 66 superficial femoral 66 neutropenia dehydration dyspnea 66 locoregional recurrence 66 nonfatal stroke 65 ascending aortic 65 elevated transaminases 65 Pegylated Liposomal Doxorubicin 65 coronary stenosis 65 Contralateral 65 QTcF 65 p = NS 65 Hypotension 65 biochemical relapse 65 creatine kinase MB 65 paclitaxel eluting stents 65 Secondary endpoints included 65 Stenosis 65 pyrexia mucositis sepsis febrile 65 thrombocytopenic 65 Serum concentrations 65 revascularizations 65 malignancy HCM 65 non valvular atrial 65 aplastic anemia AA 65 cerebrovascular accident 65 #.#/#.# mmHg [001] 65 -#.# mg dL [001] 65 hypophosphatemia 65 hemodynamically significant 65 REYATAZ r arm 65 Percutaneous Transluminal Coronary Angioplasty 65 Ischemic 65 alanine aminotransferase 65 neointimal 64 intracranial atherosclerosis 64 occlusive disease 64 receiving INTRON 64 ipsilateral stroke 64 HF hospitalization 64 lopinavir r arm 64 x ULN 64 pulmonary capillary wedge 64 bypass graft CABG surgery 64 4mg/kg 64 Atrial 64 Stomatitis 64 ALT elevation 64 perioperatively 64 CI #.#-#.# [001] 64 nadroparin 64 pT3 64 CYP#A# CYP#D# 64 Patients Undergoing 64 atheroma volume 64 Nebulized 64 myelodysplastic myeloproliferative diseases 64 Thrombotic 64 resuscitated cardiac arrest 64 descending thoracic 64 intraoperative complications 64 Tasigna prolongs 64 β blocker 64 systemic embolism 64 mU liter 64 myocardial reperfusion 64 normothermic 64 arterial thromboembolic events 64 stent binary restenosis 64 complement inhibitor eculizumab 64 renal artery stenting 64 coronary revascularization 64 tumor lysis syndrome 64 LVSD 64 systemic hypotension 64 colorectal adenoma 64 mm Stent 64 artery stenosis 64 mediastinitis 64 symptomatic VTE 64 Prognostic significance 64 Cypher Stent 64 atrioventricular block 64 crossclamp 64 serum aminotransferase levels 64 lumbar spine BMD 64 stented artery 64 leucopenia 64 J Am Coll 64 Septal 64 sirolimus stent 64 lispro 64 events thrombocytopenia neutropenia 64 severe neutropenia 64 Angiographic 64 lymphocytosis 64 peri procedural 64 Oral Fingolimod 64 myocardial infarction MI 64 sirolimus eluting stents 64 underwent surgical resection 64 left ventricular dysfunction 64 postoperative morbidity 64 angiographic restenosis 64 Postoperative 63 Left Ventricular Ejection Fraction 63 % CI #.#-#.# [007] 63 Drug eluting stent 63 % AST SGOT 63 bisoprolol 63 Patients Receiving 63 aspirin clopidogrel 63 Endometrial 63 intima media thickness 63 eplerenone 63 elevated LDH 63 perioperative complications 63 revascularisation 63 infarct size 63 stage IIIb IV 63 Known hypersensitivity 63 Ishak fibrosis score 63 aspartate aminotransferase AST 63 sirolimus eluting stent 63 cyclophosphamide methotrexate 63 postintervention 63 confidence interval #.#-#.# 63 Flu Cy 63 fatal myocardial infarction 63 leiomyomas 63 hypoperfusion 63 leukocyte count 63 ST Segment Elevation 63 adjunctive placebo 63 primary percutaneous coronary 63 Coronary Artery Bypass Graft 63 Papillary 63 Myocardial infarction 63 Thal Dex 63 TO AVOID PREGNANCY WHILE 63 SGPT 63 revascularized 63 P = .# 63 PaO 2 63 intimal hyperplasia 63 8mg/kg 63 nonischemic 63 PSA nadir 63 Is Well Tolerated 63 biochemical recurrence 63 arteriolar 63 cTnI 63 VT VF 63 postoperative mortality 63 NSTEMI 63 recurrent DVT 63 recurrent ischemia 63 sirolimus eluting 63 Abciximab 63 mL sec 63 TAXUS Liberte Long 63 #.#mg/dL 63 serum triglycerides 63 lipoprotein Lp 63 ventricular dilation 63 -#.# mg dL [002] 63 systolic function 63 hepatorenal syndrome 63 CR nPR 63 ventricular tachyarrhythmia 63 thromboembolic events 63 TIMP 1 63 postoperative complication 63 microvessel density 63 Valvular 63 aspartate aminotransferase 63 Ejection Fraction 63 FEMALES SHOULD BE ADVISED 62 triglyceride TG 62 surgically resected 62 drug eluting stent implantation 62 underwent percutaneous coronary 62 thrombophlebitis 62 intraventricular hemorrhage 62 intracerebral 62 receiving prophylactic anticoagulation 62 Taxus Stent 62 undergoing coronary artery 62 ventricular tachycardia VT 62 chronic eosinophilic leukemia 62 Atherosclerotic 62 hepatocellular carcinomas 62 postprocedure 62 artery occlusion 62 pericardial effusion 62 parenchymal 62 multivessel disease 62 Castration Resistant Prostate Cancer 62 achieved ACR# 62 recurrent glioblastoma multiforme 62 Posaconazole 62 IIIa inhibitors 62 atrioventricular valve 62 cardiovascular hospitalization 62 candesartan cilexetil 62 Percutaneous Coronary Intervention 62 Renal Artery 62 transthoracic 62 lowest tertile 62 Unstable Angina 62 mcg BID 62 intrathoracic 62 Infusion Reactions Severe 62 FluCAM arm 62 Crohn Disease Activity 62 hemodilution 62 Myocardial Infarction Study 62 hydroxymethyl coenzyme 62 carotid artery blockage 62 stomatitis pharyngitis 62 nadolol 62 DR5 62 intravesical therapy 62 intracoronary 62 QRS duration 62 transaminase elevation 62 ropivacaine 62 hemorrhagic complications 62 sodium nitroprusside 62 -#.# log# 62 reoperations 62 HES CEL 62 estramustine 62 acute peripheral arterial 62 detrusor 62 lactate dehydrogenase LDH 62 fraction LVEF 62 mL kg 62 ischemic complications 62 natriuresis 62 thromboembolism 62 Restenosis 62 TAXUS Stent 62 Lenalidomide 62 hypertrichosis occurred 62 Thrombolysis 62 Duodenal 62 Acute Myocardial Infarction 62 leukocytosis 62 cerebrovascular accidents 62 death dissection perforation 62 distal embolization thrombus formation 62 % Confidence Interval 62 malignant neoplasm 62 fibrinolytic therapy 62 bivalirudin alone 62 plus dexamethasone 62 intrahepatic 62 perioperative mortality 62 HOMA IR 62 stenoses 62 malperfusion 62 Myocardial 62 death reinfarction 62 Mg Usa 62 Levels Linked 62 troponin T 62 prolonged QT interval 62 severe exacerbations 62 rosuvastatin #mg 62 adjunctive ABILIFY 62 Non Alcoholic Steatohepatitis 62 #mmHg [001] 62 oral antidiabetic medication 62 neutropenia thrombocytopenia 62 dysuria 62 achieved CCyR 62 arterial occlusion 62 Peginterferon Alfa 2a 62 ejection fractions 62 HMG CoA reductase inhibitor 62 Subgroup analysis 62 atrioventricular node 62 silent ischemia 62 radiotherapy RT 62 β blockers 62 lactate dehydrogenase 62 grade squamous intraepithelial 62 lumbar spine bone 62 aminotransferase ALT 62 metastatic GIST 62 Infarction 62 serum creatinine levels 62 hip BMD 62 Nephrol 62 PSADT 62 ximelagatran 62 dose atorvastatin 62 ventricular dilatation 62 moderate renal impairment 62 Diastolic 62 isoenzyme 61 albumin excretion rate 61 Adjunctive 61 FUSILEV enhances 61 binary restenosis rate 61 preoperative PSA 61 inducible nitric oxide synthase 61 HBeAg negative patients 61 highest tertile 61 hyperacute 61 thoracoabdominal 61 hypoxemia 61 receiving PEGINTRON 61 intratumoral 61 urgent revascularization 61 Free Survival PFS 61 nmol liter 61 hematological parameters 61 oxycodone CR 61 Infarct 61 unresectable tumors 61 paclitaxel cisplatin 61 Fasting blood glucose 61 saphenous vein grafts 61 Asymptomatic 61 Intravitreal 61 TAXUS Express2 61 peripheral arterial occlusive disease 61 target lesion revascularizations 61 cardiovascular hospitalizations 61 stented vessel 61 hepatic vein 61 ALT normalization 61 lung esophageal 61 certolizumab 61 Myoglobin 61 ischemic lesions 61 mg hydrochlorothiazide 61 ventricular dysfunction 61 TRAIL R1 61 Hepatic 61 mcg kg REBETOL 61 recurrent VTE 61 recurrent venous thromboembolism 61 Thromboembolism 61 Mg Uk 61 Folfox 61 definite stent thrombosis 61 Atypical Hemolytic Uremic Syndrome 61 primary patency 61 LVEF 61 surgical revascularization 61 Major Adverse Cardiac 61 ® lenalidomide 61 J Am Soc 61 Val HeFT 61 pamidronate 61 moderate hepatic impairment 61 generalized edema 61 elevated creatinine 61 liver decompensation 61 gastroduodenal 61 BMS p = 61 transurethral 61 estimated glomerular filtration 61 MADRS score 61 asthenia fatigue 61 Elderly Patients 61 neutropenic sepsis 61 median sternotomy 61 Am J Cardiol 61 severe mitral regurgitation 61 ertapenem 61 angiotensin converting enzyme inhibitor 61 conjunctival hyperemia 61 mmHg diastolic 61 glomerular filtration 61 patients undergoing percutaneous 61 HER2 expression 61 transarterial 61 workhorse lesions 61 transaminases 61 non splenectomized 61 5 hydroxytryptamine 61 ACE Inhibitors 61 Hazard Ratio 61 J Shoulder Elbow 61 Intra arterial 61 progressive dyspnea 61 thromboembolic 61 Intracerebral Hemorrhage 61 splenectomized 61 angioplasty stenting 61 stenotic 61 mitral stenosis 61 T2 lesion volume 61 serum calcium levels 61 PRADAXA #mg 61 pruritus rash 61 Ribavirin causes 61 afterload 61 K ras mutations 61 annualized relapse 61 Prospective Randomized 61 pretransplant 61 aneurysms AAA 61 bone marrow reticulin deposition 61 symptomatic intracranial hemorrhage 61 arteriovenous fistula 61 distensibility 61 PROCTOCORT R 61 fibrin deposition 61 alfuzosin 61 log# copies mL 61 intact parathyroid hormone 61 undergoing coronary angiography 61 anastomotic leak 61 systolic dysfunction 61 parathyroid carcinoma 61 renal artery stenosis 61 Caveolin 1 61 humanized interleukin 6 61 included exfoliative dermatitis 61 alteplase 61 Peripheral Arterial 61 uM 61 induce orthostatic hypotension 61 progression TTP 61 mediated dilation 61 Kaplan Meier estimates 61 #mg BID [001] 61 irbesartan 61 CLINICAL STUDIES 61 prednisone prednisolone plus 61 SGOT 61 serum phosphorous 61 mild renal impairment 61 radial artery grafts 61 transurethral resection 61 Achieves Primary Endpoint 61 Index CDAI 61 akinesia 61 stent thromboses 61 underwent resection 61 pulmonary alveolar 61 Pioglitazone 61 Aortic valve 61 Prolongs Survival 61 glomerular 61 patients undergoing CABG 61 progesterone receptor negative 61 TNF Tumor Necrosis Factor 61 everolimus eluting stents 61 hepatic enzyme 61 Adefovir 61 umbilical artery 61 primidone 61 Vidaza ® 61 sternal wound infection 61 Tumor Response 61 neutrophil counts 61 Acute Coronary Syndromes 61 lumen diameter 61 stroke myocardial infarction 61 cerebral vasospasm 61 pretest probability 61 Acetate Rectal Suppositories 61 echocardiographic parameters 61 mycophenolic acid 61 Complication rates 61 sunitinib Sutent 61 receiving VELCADE 61 CrCl 61 pooled comparator 61 saline placebo 61 stable angina pectoris 61 See WARNINGS 61 percutaneous transluminal coronary angioplasty 61 LPS induced 61 saphenous vein graft 61 pulmonary artery banding 61 GP IIb IIIa inhibitors 61 artificial arteriovenous dialysis 61 % CI #.#-#.# [006] 61 Hazard Ratio HR 61 SCr 61 Thrombocytopenia 61 Score TOS 61 metoprolol tartrate 61 vitreous floaters 61 Myocardial Infarction 61 receiving XGEVA 61 angiotensin converting enzyme inhibitors 61 uncoated stent 61 Cardiopulmonary bypass 61 Carotid artery 61 preintervention 61 coagulopathy 60 cough dyspnea 60 mg subcutaneous 60 interferon beta 1a infertility 60 mesangial 60 DG# compounds targeting 60 Chronic Heart Failure 60 advanced adenoma 60 haematologic 60 unresectable HCC 60 ug dose 60 glycoprotein IIb IIIa inhibitor 60 cisplatin gemcitabine 60 serum urate 60 peritumoral 60 hypervascular tumors 60 Non Responders 60 CsA 60 intracerebral hemorrhage ICH 60 gadolinium enhancing lesions 60 relapsed MM 60 sensory neuropathy 60 cytopenias 60 Postoperative complications 60 postoperative AF 60 specific alkaline phosphatase 60 pancreas esophagus 60 thrombocytosis 60 metachronous 60 aneurysmal 60 proximal DVT 60 TAXUS Express Atom Stent 60 Novel Oral 60 intravascular hemolysis 60 doxorubicin cyclophosphamide 60 undergoing percutaneous coronary 60 osteoclastic 60 Intracoronary 60 TEAEs 60 NYHA Class II 60 % CI #.#-#.# [003] 60 appendiceal 60 tumor xenograft models 60 pg ml 60 capillary leak 60 atorvastatin #mg 60 Carcinomas 60 flutamide 60 #mm Hg 60 plasminogen activator inhibitor 60 HBeAg seroconversion 60 apolipoprotein B 60 cardiac tamponade 60 Angiotensin Converting Enzyme 60 thrombotic complications 60 arteriography 60 Nesiritide 60 ipsilateral 60 5 FU leucovorin 60 descending thoracic aorta 60 chemoradiation therapy 60 #Gy 60 fluorouracil leucovorin 60 Naive Patients 60 alanine aminotransferase ALT 60 liver histology 60 nodal metastasis 60 AST ALT 60 reactive hyperemia 60 nonobstructive CAD 60 noninferior 60 ATV RTV 60 Partial Response 60 leukocyte counts 60 somatostatin analog 60 Cardiac Troponin 60 ABCB1 60 FOLFOX4 alone 60 reteplase 60 vertebrobasilar 60 Hormone Refractory Prostate Cancer 60 pulmonary metastasis 60 polycythemia vera essential thrombocythemia 60 inotropic agents 60 AUC0 60 left ventricular LV 60 systolic hypertension 60 branch retinal vein 60 ventricular fibrillation VF 60 Cypher Sirolimus 60 PEGylated Fab fragment 60 paresthesias 60 deep vein thromboses 60 Severe Sepsis 60 Hemolysis 60 headache abdominal pain 60 variceal hemorrhage 60 adnexal mass 60 liver metastasis 60 collagenous colitis 60 Improves Outcomes 60 renal pelvis 60 elevated lipase 60 heparin induced thrombocytopenia 60 fatal pulmonary embolism 60 calcified plaques 60 ATACAND 60 Bivalirudin 60 ischemic cardiomyopathy 60 potent CYP#A# inhibitors 60 abacavir lamivudine 60 aminotransferases 60 LDL triglycerides 60 lipid lowering agents 60 interleukin IL -6 60 pancreatic prostate 60 FOLFOX6 60 Antihypertensive 60 Myeloid 60 #.#/#.# mm Hg [003] 60 vasopressor 60 Renal dysfunction 60 clinicopathological features 60 leukopenia 60 enalapril 60 elevated ALT 60 peripheral artery 60 CI #.#-#.# [002] 60 = #.#-#.# 60 purpura ITP 60 pneumonectomy 60 Aortic Valve 60 onset diabetes mellitus 60 urgent coronary revascularization 60 Randomized Evaluation 60 arterial revascularization 60 multivariate Cox 60 noncardiac 60 excess blasts RAEB 60 hyperalgesia 60 Subarachnoid hemorrhage 60 ‰ ¥ 60 carotid revascularization 60 thrombocytopenia neutropenia 60 angiotensin II receptor blockers 60 retinal vein occlusion induced 60 IOP lowering 60 inhibitor SNRI 60 rs# [004] 60 Stenting 60 hip osteonecrosis avascular 60 Relapsing Remitting Multiple Sclerosis 60 CCyR 60 creatinine ratio 60 myocardial infarctions 60 hepatic metastases 60 serum cortisol 60 intraventricular 60 mg qd 60 Ventricular Tachycardia 60 elevated serum creatinine 60 gastrointestinal perforation 60 spinal cord compression 60 CK # administered 60 Fracture Risk 60 microgram kg 60 revascularization procedures 60 insulin glulisine 60 benazepril 60 NSTE ACS 60 nonvertebral 60 advanced adenomas 60 Cardiac Resynchronization 60 corticotropin 60 Renal Impairment 60 hyperemia 60 J Foot Ankle 60 PEG IFN 60 left ventricular diastolic 60 Proteinuria 60 oral levofloxacin 60 femoral popliteal 60 mg clopidogrel 60 creatine kinase CK 60 ENL recurrence 60 #-# Full Text 60 gadolinium enhancing 60 TAXUS Liberté stent 60 CDAI 60 hepatic enzymes 60 Amgen Neulasta R 60 Thromboembolic 60 Clinically significant 60 glycoprotein IIb IIIa inhibitors 60 EURIDIS 60 -#.# log# copies mL 60 peripheral neuropathy aggravated 60 essential thrombocythemia ET 60 hyperintensity 60 DES implantation 60 postoperative delirium 60 myocardial infarction hypersensitivity 60 confidence interval CI 60 Secondary Hyperparathyroidism 60 Losartan 60 eptifibatide 60 fulminant hepatic failure 60 myocardial necrosis 60 sinus tachycardia 60 NovoSeven ® 60 protein excretion 60 fluvastatin 60 CABG coronary artery 60 MR Angiography 60 oxycodone IR 60 abdominal pain headache 60 AVAPRO 60 gadolinium enhanced 60 autoantibody levels 60 pulmonary vascular 60 angioneurotic edema 60 angiographic outcomes 60 quetiapine risperidone 60 noninvasive outpatient 60 valvular disease 59 % CI #.#-#.# [008] 59 thrombosis embolism 59 percutaneous intervention 59 Nilotinib 59 sinus node dysfunction 59 myocardial infarction 59 coadministration 59 CIMZIA TM certolizumab pegol 59 FDG uptake 59 mg kg ip 59 Doxil ® 59 carotid artery stenting CAS 59 secondary efficacy endpoint 59 either ischemic clog 59 -#.# ± [002] 59 vaso occlusive crisis 59 pulmonary metastases 59 colorectal carcinomas 59 extrapyramidal symptoms 59 obstructive CAD 59 resynchronization therapy 59 pericardial effusions 59 Fulvestrant 59 cerebral perfusion 59 chronic thromboembolic pulmonary 59 triglycerides TG 59 recurrent myocardial infarction 59 PREZISTA r arm 59 trimethoprim sulfamethoxazole 59 transmural 59 ug kg 59 Microvascular 59 fibrinolytic 59 abnormal p# biomarker 59 esophagus bladder 59 thrombotic events 59 esophageal carcinoma 59 tertiles 59 Intracranial Aneurysms 59 prespecified secondary 59 transaminase 59 Orthostatic Hypotension 59 colorectal carcinoma 59 REMINDER ORLive Presents 59 NPH insulin 59 linaclotide treated 59 Peginterferon 59 hematologic toxicity 59 lymph node metastasis 59 confidence intervals CIs 59 chronic immune thrombocytopenic 59 multivariate adjustment 59 Endarterectomy 59 preserved ejection fraction 59 Dilatation 59 cardiac dysfunction 59 rs# [002] 59 serum phosphate 59 rCBF 59 discontinuations due 59 liver transaminases 59 repeat paracentesis 59 olmesartan 59 contrast induced nephropathy 59 Intrathecal 59 cortisol synthesis 59 reblockage 59 hyperphenylalaninemia HPA due 59 tricuspid regurgitation 59 constipation dizziness 59 resistant hormone refractory 59 μmol L 59 Microalbuminuria 59 ischemia induced 59 mmol l 59 urothelial 59 undergo percutaneous coronary 59 Vascular Disrupting Agent 59 systolic ejection 59 HBeAg negative 59 VEGF induced 59 hepatic veins 59 asystole 59 apo B 59 papillary renal cell carcinoma 59 carotid endarterectomy CEA 59 hypointense 59 p = #.# [003] 59 radical nephrectomy 59 ACE Inhibitor 59 adrenalectomy 59 endoleak 59 placebo dexamethasone 59 cervical lymph nodes 59 UA NSTEMI 59 vinorelbine tartrate 59 mesenteric 59 Angiograms carry slight 59 Significantly Reduced 59 Plasma concentrations 59 PEGylated anti 59 Septic Shock 59 q#h 59 liver resection 59 monocyte chemotactic protein 59 See CLINICAL PHARMACOLOGY 59 bronchial hyperresponsiveness 59 LOVENOX 59 Antiplatelet 59 trabeculectomy 59 cisplatin vinorelbine 59 statistically significant p = 59 infliximab monotherapy 59 sonographically 59 μg kg 59 hepatocellular 59 metastatic neuroendocrine tumors 59 R# #mg BID 59 NovoLog ® Mix 59 autoregulation 59 neutropenic fever 59 Pulmonary Artery 59 â ‰ ¥ 59 vasospasm 59 drotrecogin alfa activated 59 PROCTOCORT ® Suppository Hydrocortisone 59 platelet reactivity 59 intraperitoneally 59 histological subtype 59 mitoxantrone chemotherapy 59 Acute Coronary 59 FOLFOX4 59 daily subcutaneous injections 59 Thrombotic thromboembolic complications 59 sumatriptan naproxen sodium 59 Double Blind Randomized 59 warfarin erythromycin 59 ® fluocinonide Cream 59 Primary endpoints 59 adenomatous 59 stent stenosis 59 composite endpoint 59 receptor blocker 59 Carotid 59 ST elevation myocardial 59 thromboses 59 thrombus formation 59 invasive ductal 59 metastatic pancreatic 59 leiomyoma 59 Bare Metal Stent 59 thymectomy 59 pulmonary arterial 59 Fasting plasma glucose 59 Thiazolidinediones 59 prospectively stratified 59 Ann Oncol 59 torsade de pointes 59 mild renal insufficiency 59 colorectal liver metastases 59 ST Elevation Myocardial 59 Hemorrhagic stroke 59 homozygotes 59 gefitinib Iressa 59 cardiogenic shock 59 bevacizumab Avastin R 59 bronchoalveolar lavage 59 retransplantation 59 asymptomatic carotid stenosis 59 infusional 59 diastolic BP 59 duodenal 59 cell adhesion molecule 59 STRIDE PD 59 scleral buckling 59 nasopharyngitis headache 59 Intravenous immunoglobulin 59 pT2 59 vomiting PONV 59 infarction NSTEMI 59 comparator arm 59 NYHA functional class 59 intravenous bolus 59 nondiabetics 59 thyrotoxicosis 59 metaplasia 59 octreotide LAR 59 hemorrhagic bleeding 59 Secondary endpoints include 59 polypoid 59 mineralocorticoid receptor 59 carotid artery intima media 59 Hypertrophy 59 p = .# [002] 59 lymphopenia 59 CLL SLL 59 neurologic complications 59 balloon valvuloplasty 59 renal cysts 59 alanine transaminase 59 wedge resection 59 total abdominal hysterectomy 59 intermittent hemodialysis 59 vWD 59 NYHA Class III 59 urethral stricture 59 infarctions 59 aortic crossclamp 59 Systolic 59 hemoglobin Hb 59 plasma lipids 59 cEVR 59 liposomal amphotericin B 59 ventricular septum 59 oral Hycamtin 59 recurrent ischemic